期刊文献+

NQO1基因ns-cSNP与淮安汉族人群食管癌易感性的关系 被引量:6

Relationship between quinone oxidoreductasel gene ns-cSNP and genetic susceptibility of esophageal cancer
原文传递
导出
摘要 目的探讨依赖还原型辅酶Ⅰ/Ⅱ醌氧化还原酶1(quinone oxidoreductasel,NQO1)基因非同义编码 SNP(C609T、C465T、G406C)与淮安汉族人群食管癌易感性的关系。方法采用1:1配对的病例-对照研究,选择淮安地区原发性食管癌患者和对照者各106例。采用 PCR-RFLP 和 AS—PCR 技术检测研究对象的基因型,比较不同基因型与食管癌易感性的关系。结果在对照组与病例组中均未检测到 NQ01 406C/C 基因型;未发现 NQO1 CA65T 多态性与淮安汉族人群食管癌易感性的关系;携带 NQ01 609T 等位基因的个体与对照组相比,其患食管癌的易感性升高(OR=4.76,95%CI=1.064~3.397)。结论 NQ01 C609T 基因多态可能与食管癌的发生有关。 Objective To explore the relationship between quinone oxidoreductasel (NQO1) gene nonsynonymous cSNP and the genetic susceptibility of esophageal cancer. Methods Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and Allele-Specific PCR (AS-PCR) were employed to assess the polymorphism of NQO1 genes both in 106 patients with esophageal cancer and control subjects matched by age, gender and origin. Results It was shown that no C/C genotype was found at 406 of NQO1. The allelic frequency of NQO1 609T was significantly higher in patients with esophageal cancer than in the control subjects (P 〈 0. 005 ) and the individuals with 609T allelic genotype of NQO1 gene were at greater risk to develop esophageal cancer( OR = 4. 76, 95% CI = 1. 064 - 3. 397 ). But Individuals with mutant allele of NQO1 465 genotype did not show the rising risk of esophageal cancer. Conclusion The NQO1 C609T polymorphisms should likely be associated with the genetic susceptibility of esophageal cancer.
出处 《中华预防医学杂志》 CAS CSCD 北大核心 2006年第5期324-327,共4页 Chinese Journal of Preventive Medicine
基金 国家自然科学基金(30571540) 江苏省卫生厅预防医学基金(Y2004025) 东南大学科技基金(XJ0525212)
关键词 依赖还原型辅酶Ⅰ/Ⅱ醌氧化还原酶1 食管肿瘤 多态性 单核苷酸 NAD(P)H: quinine oxidoreductasel Esophageal neoplasms Polymorphism,single nucleotide
  • 相关文献

参考文献12

二级参考文献66

  • 1[1]Jaiswal AK, McBride OW, Adesnik M, et al. Human dioxininducible cytosolic NAD(P)H: menadione oxidoreductase. cDNA sequence and localization of gene to chromosome 16[J]. J Biol Chem, 1988, 263(27): 13572~13578
  • 2[2]Tvaver RD, Horikosh T, Danenberg KD, et al. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity [J]. Cancer Res, 1992, 52(4): 797~802
  • 3[3]Monks TJ, Hanzlik RP, Cohen GM, et al. Quinone chemistry and toxicity[J]. Toxicol Appl Pharmacol, 1992, 112(1): 2~16
  • 4[4]Siegel D, Anwar A, Winski SL, et al. Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD (P)H:quinone oxidoreductase 1 [J]. Mol Pharmacol, 2001, 59(2):263 ~268
  • 5[5]Kuehl BL, Paterson JW, Peacock JW, et al. Presence of a heterozygous substitution and its relationship to DT-diaphorase activity[J]. Br J Cancer, 1995, 72(3): 555~561
  • 6[6]Kelsey KT, Ross D, Traver RD, et al. Ethnic variation in the prevalence of a common NAD (P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy[J]. BrJ Cancer, 1997, 76(7): 852~854
  • 7[7]Gaedigk A, Tyndale RF, Jurima-Romet M, et al. NAD(P)H:quinone oxidoreductase: polymorphisms and allele frequencies in Caucasian, Chinese and Canadian Native Indian and Inuit populations[J]. Pharmacogenetics, 1998, 8(4): 305~313
  • 8[8]Long DJ 2nd, Waikel RL, Wang XJ, et al. NAD (P)H:quinone oxidoreductase 1 deficiency and increased susceptibility to,12-dimethyl-benz [a]-anthracene induced carcinogenesis in mouse skin[J]. J Natl Cancer Inst, 2001, 93(15): 1166~1170
  • 9[9]Asher G, Lotem J, Cohen B, et al. Regulation of p53 stability and p53-dependent apoptosis by NADH quinoneoxidoreductase 1[J]. Proc Natl Acad Sci USA, 2001, 98(3): 1188~1193
  • 10[10]Asher G, Lotem J, Kama R, et al. NQO1 stabilizes p53through a distinct pathway[J]. Natl Acad Sci USA, 2002, 99(5): 3099~3104

共引文献46

同被引文献44

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部